2/24
08:15 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $98.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $98.00 price target on the stock.
2/24
08:02 am
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/24
08:02 am
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/24
07:15 am
bmrn
BioMarin upgraded to Outperform from Perform at Oppenheimer
Low
Report
BioMarin upgraded to Outperform from Perform at Oppenheimer
2/24
07:15 am
bmrn
BioMarin upgraded to Outperform from Perform at Oppenheimer
Low
Report
BioMarin upgraded to Outperform from Perform at Oppenheimer
2/20
06:14 pm
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $94.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $94.00 price target on the stock.
2/20
06:14 pm
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $94.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $94.00 price target on the stock.
2/20
01:47 pm
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/20
01:47 pm
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/20
01:36 pm
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/20
01:36 pm
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/20
11:13 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
2/20
11:13 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
2/20
11:06 am
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/20
11:06 am
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/20
10:20 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $90.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $90.00 price target on the stock.
2/20
10:14 am
bmrn
Rating for BMRN
Low
Report
Rating for BMRN
2/20
09:37 am
bmrn
Rating for BMRN
Low
Report
Rating for BMRN